• Cite Icon7
  • https://doi.org/10.1161/circgenetics.110.957761Copy DOI Icon

Clinical Proteomics

Show More
  • Abstract
  • Literature Map
  • References
  • Citations
  • Similar Papers
Abstract

Clinical proteomics involves the analysis of protein expression of disease proteomes, with the aim of solving a specific clinical problem. Discoveries made from proteomicbased studies contribute to the growing need for innovative medical diagnostics for disease detection. Taking into consideration the global health burden of cardiac disease, clinical proteomics is a valuable tool to improve risk stratification associated with this disease. In cardiovascular medicine, the identification of novel proteins, or biomarkers, that are differentially expressed in cardiac disease proteomes may enable early detection of the disease state, thereby preventing progression to disease end points. This review outlines various proteomic platforms and their technical advancements and relates these to the cardiovascular sciences. The entire protein complement of the cell, or proteome, is dynamic and changes in response to the disease state. 1 Proteomic-based experiments can be used to characterize such alterations in protein expression during disease progression. 2 With combined improvements in mass spectrometry (MS) technology as well as innovative molecular biology screening tools, there has been widespread growth in the characterization of cardiac disease proteomes. In fact, proteomic technology has been an important tool in the analysis of heart failure (HF), 3,4 cardiac hypertrophy, 5,6 and dilated cardiomyopathy.7 Several of the overarching aims of such studies include providing greater understanding of general biological mechanisms as well as identifying unique proteins that are clinically useful in the detection of cardiac disease in the early stages or potentially used as novel therapeutic targets. Clinical proteomics continues to benefit from advancements in technologies that allow for fast and consistent identification of proteins with corresponding increases in the dynamic range of proteins detectable in the disease proteome. MS-related technologies have improved in their ability to detect low-abundance proteins as well as membrane proteins and have benefited from sample preprocessing strategies that decrease the complexity of large-scale analyses. With the emergence of different methodologies for biomarker identification, the following 3 criteria must be taken into careful consideration to determine whether the protein is, in fact,

Similar Papers
  • Research Article
  • Citations37

Improvement of an in-gel tryptic digestion method for matrix-assisted laser desorption/ionization-time of flight mass spectrometry peptide mapping by use of volatile solubilizing agents.

  • Nov 01, 2001
  • PROTEOMICS
  • Vukic Soskic +1
  • Research Article
  • Citations2

Hyperdeviation and static ocular counterroll in unilateral abducens nerve palsy.

  • Apr 01, 2002
  • Annals of the New York Academy of Sciences
  • Agnes M.F Wong +2
  • Research Article
  • Citations5

A Candidate Hypertension Gene

  • Mar 08, 2007
  • Circulation Research
  • Scott Heximer +1
  • Research Article
  • Citations98

The Diversity of Bioactive Proteins in Australian Snake Venoms

  • Jun 01, 2007
  • Molecular & Cellular Proteomics
  • Geoff W Birrell +6
  • Research Article

Postoperative complications among obstructive sleep apnea patients

  • Jun 01, 2007
  • Canadian Journal of Anesthesia/Journal canadien d'anesthésie
  • Balaji Yegneswaran +4
  • Book Chapter
  • Citations1

Identification of Chemical-Adducted Proteins in Urine by Multi-dimensional Protein Identification Technology (LC/LC–MS/MS)

  • Sep 30, 2010
  • Matthew T Labenski +3
  • Research Article
  • Citations134

Complete characterization of posttranslational modification sites in the bovine milk protein PP3 by tandem mass spectrometry with electron capture dissociation as the last stage.

  • Apr 12, 2003
  • Analytical Chemistry
  • Frank Kjeldsen +4
  • Research Article
  • Citations5

Abstracts for Canadian Stroke Conference

  • Nov 01, 2012
  • Stroke
  • Lippincott Williams Wilkins
  • Research Article
  • Citations68

Off-Line Multidimensional Liquid Chromatography and Auto Sampling Result in Sample Loss in LC/LC-MS/MS.

  • Jul 21, 2014
  • Journal of Proteome Research
  • Sameh Magdeldin +3
  • Research Article
  • Citations2

Proteomic basics — quantification and post-translational modifications of proteins: The 3rd European Summer School in Kloster Neustift

  • Nov 18, 2009
  • Journal of Proteomics
  • Katrin Marcus +2
  • Research Article
  • Citations92

Proteomics and Glycomics Analyses of N-Glycosylated Structures Involved in Toxoplasma gondii-Host Cell Interactions

  • May 01, 2008
  • Molecular & Cellular Proteomics
  • Sylvain Fauquenoy +7
  • Research Article
  • Citations31

FROM THE DECLINE AND FALL OF PROTEIN CHEMISTRY TO PROTEOMICS

  • Mar 01, 2002
  • BioTechniques
  • Deb N Chakravarti
  • Research Article
  • Citations180

Proteomics Analysis of Human Amniotic Fluid

  • Aug 01, 2007
  • Molecular & Cellular Proteomics
  • Chan-Kyung J Cho +3
  • Front Matter
  • Citations13

New Guidelines for Clinical Proteomics Manuscripts

  • Nov 01, 2008
  • Molecular & Cellular Proteomics
  • Julio E Celis +2
  • Research Article

Shining a spotlight on intact proteins

  • May 01, 2014
  • PROTEOMICS
  • Ljiljana Paša-Tolić +1
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.